Owner Thrasos Therapeutics, Inc.

Inventors Carlson, William D.; Keck, Peter C.; Sworin, Michael; Bosukonda, Dattatreymurty

Agent Davies Collison Cave

Pub. Number AU-A-2012201060

Parent 2006292147

Filing date 23 February 2012

Wipo publication date 15 March 2012

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent